Private Equity

The asset manager's May report reveals $3.3B in net inflows, driven by a major target date fund win, underscoring its market resilience and leadership.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

As millions of owners face retirement, a new firm is offering an alternative to the PE playbook of quick flips, promising to hold businesses forever. Is this the future?

With its third North American acquisition in two years, Axiom GRC isn't just buying a firm—it's buying a strategic foothold in the future of AI governance.

With a novel 'gastric bypass in a pill' and a new CFO known for orchestrating lucrative exits, Syntis Bio is gearing up for a high-stakes battle in the booming obesity drug market.

A Houston private equity firm just sold off its Permian Basin assets for an undisclosed sum, but the real story is the blueprint it reveals for profiting from a frenzied M&A market.

By adding a public company CFO and a veteran tech investor, AI chipmaker Syntiant is laying the groundwork for aggressive scaling and a potential public offering.

With new CEO Craig Mengert and backing from Altaris, Tegria is pivoting to an AI-first strategy, aiming to reshape healthcare tech modernization.

With a new $4.3B war chest, Hunter Point Capital is evolving from a GP stakes firm into a scaled solutions platform, meeting a critical need for liquidity.

Market research shows doctors are eager to prescribe Moleculin's new AML drug, Annamycin. It offers hope where there is none, but can the company survive to deliver it?

Julie Mueller's move to acquire 100% of Custom Design Benefits isn't just a transaction; it's a strategic bet on independence in a consolidating market.

Drucker + Falk's new CPO and Chief of Staff roles aren't just promotions; they're a blueprint for scaling a legacy firm under new private equity ownership.

As NEXGEL prepares for a key investor conference, it faces a crucial test: convincing the market its advanced hydrogel tech can overcome recent financial hurdles.

GoHealth's third straight Georgia Fast 40 win isn't just an award; it's a signal. We dissect the 'connected care' model driving its explosive growth.

A record $98.3T in HNWI wealth creates a fierce battle for assets, as traditional firms lose ground to tech-savvy rivals and AI-driven personalization.

In nine years, Wellington-Altus hit $50B AUA and a 7th top-dealer award. It's more than growth; it’s a strategic coup for advisor independence.

Titans of finance, tech, and policy will converge at the CAIS Summit to navigate AI's impact and geopolitical shifts on the future of alternative investments.

With the hire of veteran Dr. Jesko Kornemann, advisory firm Cork Gully makes a strategic push into Frankfurt, betting on a growing need for special situations expertise.

With a major investment from PSG, Dockwa is using AI to transform the $57B marina economy, turning fragmented businesses into a new institutional asset class.

Innesto Partners' acquisition of German specialist Hausmann Aero isn't just a deal; it's a strategic play using the search fund model to bolster Europe's defense autonomy.